According to a panel of drug experts, the use of powerful antipsychotic drugs to treat disorders in children is a dangerous practice. Risperdal, known as an “atypical” antipsychotic, had been used by doctors to treat attention deficit disorder (ADD). Nearly 400,000 children and teenagers have been treated with Risperdal in the past year.
Risperdal has not been approved for attention deficit conditions. The drug also has several dangerous side effects. In many cases, the patient’s metabolism may be affected, causing significant weight gain. Other patients develop muscular twitches, tics, or spasms, which can become permanent. Other drugs in the same class as Risperdal are Abilify, Geodon, Seroquel, and Zyprexa.
The panel was originally convened by the Food and Drug Administration (FDA) as part of a routine review procedure for Risperdal and Zyprexa. The FDA requested that the panel review and approve the agency’s oversight of the manufacturers and sign off on the agency’s efforts at warning against the risks involved with the drugs. The panel rejected the FDA’s proposed course of action and felt that stronger warnings were needed. The experts felt that the potential side effects were too dangerous to justify the risk in prescribing the drugs for attention disorders.
Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.
Lilly Zyprexa ' Chemical Straitjacket' Use by Children.Zyprexa,as well as the other atypical antipsychotics, are being prescribed for children, even though this is an unapproved, off-label use. Eli Lilly has been charged in allegedly pushing the drug for children in more than one state. A report by Dr. Cooper at Vanderbilt University states that 2.5 million children are now taking atypical antipsychotics. Over half are being given them for Attention Deficit Hyperactivity Disorder. Perhaps it is statistics like these that caused the FDA to finally require warnings on the labels of the ADHD drugs. The use of atypical antipsychotics for children should be banned. Daniel Haszard More ...
Many of the atypical antipsychotics have been on the market since the nineties. Originally approved for adults with schizophrenia and manic depression, 30,000 people or their families sued for Zyprexa alone - damages of death and diabetes predominately. Then the companies found a new target - seniors with dementia (off label use). There have been so many deaths from this a black box warning has been placed, if ignored. Now, the greed-driven makers have turned to children - predominately for "ADD" - a dubious diagnosis, and "pediatric bipolar disorder" - an unproven diagnosis.These drugs must be banned for children, as children are our future.
Keep up with the latest updates using your favorite RSS reader
Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.
Looking for an InjuryBoard attorney closer to home? Click here.
Enter your email address if you would like to receive email notifications when comments are made on this post.
Blogging for Michigan
Christine Barry
Detroit Injury Lawyer
Emptywheel
Legal Reform in the News
LSJ Blogs
Michigan Lawyers Weekly Blog
Michigan Liberal
Michigan Supreme Court from MI Auto Law
My Left Pinkie
Tort Deform
Traverse City Accident Attorney
Updates in Michigan Family Law
Find an InjuryBoard Blog in your area:
Alabama
Birmingham
Gadsden
Huntsville
Mobile
Montgomery
Alaska
Anchorage
Fairbanks
Arizona
Chandler
Phoenix
Scottsdale
Tucson
Arkansas
Bentonville
El Dorado
Jonesboro
Little Rock
Mountain Home
California
Bakersfield
Chico
Fresno
Glendale
Huntington Beach
Lancaster
Long Beach
Los Angeles
Modesto
Novato
Oakland
Orange County
Redding
Sacramento
San Diego
San Diego County
San Francisco
San Jose
San Luis Obispo
Santa Clarita
Stockton
Ventura
Colorado
Colorado Springs
Denver
Fort Collins
Grand Junction
Connecticut
Hartford
New Haven
Waterbury
District of Columbia
Metro D.C.
Washington
Florida
Central Florida
Fort Lauderdale
Ft. Myers
Gainesville, Ocala & Daytona Beach
Jacksonville
Melbourne
Miami
Orlando
Pensacola
Sarasota
Tallahassee
Tampa Bay
West Palm Beach
Georgia
Atlanta
Hawaii
Honolulu
Idaho
Boise
Illinois
Chicago
Chicago-Land
Cook County
Rockford & Moline
Springfield
Indiana
Bloomington
Indianapolis
Iowa
Council Bluffs
Davenport
Des Moines
Fort Dodge
Waterloo
Kansas
Topeka
Wichita
Kentucky
Bowling Green
Louisville
Paducah
Louisiana
Baton Rouge
Lafayette
New Orleans
Maine
Bangor & Augusta
Maryland
Baltimore
Massachusetts
Boston
Cape Cod
Stoughton / Canton
Michigan
Detroit
Grand Rapids
Lansing
Traverse City
Minnesota
Minneapolis
St. Cloud
Mississippi
Biloxi & Gulfport
Tupelo
Missouri
Jefferson City
Kansas City
St. Louis
Montana
Missoula
Nebraska
Lincoln
Omaha
Nevada
Las Vegas
Reno
New Hampshire
New Jersey
Bergen County
Cherry Hill
Jersey City
Newark
Trenton
New York
Buffalo
Long Island
New York City
Northern New York
Syracuse
North Carolina
Charlotte
Fayetteville
Greensboro
Greenville, OBX & Rocky Mount
Raleigh
Wilmington
Ohio
Akron
Cincinnati
Cleveland
Columbus
Dayton
Findlay
Sandusky
Toledo
Oklahoma
Oklahoma City
Tulsa
Oregon
Portland
Pennsylvania
Philadelphia
Rhode Island
Providence
South Carolina
Charleston
Columbia
Florence / Myrtle Beach
Greenville
Spartanburg
Tennessee
Chattanooga
Nashville
Texas
Austin
Beaumont
Brownsville
Corpus Christi
Dallas
Galveston Bay
Houston
Laredo
McAllen
North Dallas
San Antonio
Tyler
Victoria
Waco
Utah
Salt Lake City
Vermont
Virginia
Charlottesville
Fairfax, Leesburg & Loudoun
Norfolk, Portsmouth & Hampton
Northern Virginia
Richmond
Roanoke
Virginia Beach, Chesapeake & Suffolk
Everett
King County
Olympia
Seattle
Tacoma
Vancouver
West Virginia
Wisconsin
Milwaukee
Wyoming
Cheyenne